Status:
UNKNOWN
Pacing in Left Ventricular Assist Device Recipients
Lead Sponsor:
Finn Gustafsson
Conditions:
Heart Rate
Chronotropic Incompetence
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Implantation with left ventricular assist device (LVAD) in patients with end-stage heart failure (HF) leads to improvements in survival and quality of life, however, work capacity remains disappointin...
Detailed Description
While implantation with left ventricular assist devices (LVADs) in patients with end-stage heart failure (HF) improve survival and quality of life, work capacity remains at a disappointing 50% of the ...
Eligibility Criteria
Inclusion
- Implanted with a left ventricular assist device
- Implanted with a pace-device ensuring the possibility of pacing
- Age \> 18
Exclusion
- Not able to undergo a peak oxygen uptake test
- No consent
Key Trial Info
Start Date :
April 23 2019
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
January 31 2021
Estimated Enrollment :
15 Patients enrolled
Trial Details
Trial ID
NCT03844516
Start Date
April 23 2019
End Date
January 31 2021
Last Update
June 2 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Rigshospitalet
Copenhagen, DK, Denmark, 2100